SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " drug " 1,594 found 🔀 AI-powered Shuffle
Large Sterling Heights police operation swarms SW Detroit business
Also at the scene was the Drug Enforcement Agency, K-9 police units and officers wearing tactical fatigues and helmets.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Biotech experts want FDA drug reviews based on science, not politics
July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want assurance that politics will not interfere in the agency's drug-review process.
Does the science of peptides live up to the hype?
Synthetic peptides are getting some serious hype, from fitness influencers on your FYP to people seeking new options for chronic conditions. And while the human body already makes peptides, like insulin and the hormone oxytocin, most of the viral synthetic peptides are not approved by the Food and Drug Administration. Scientists say that raises some big concerns about safety and efficacy. So ahead of this week’s FDA meeting to discuss seven commonly used peptides, we get into the science with health reporter Sarah Boden.Interested in more science behind health trends? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. It includes perks like bonus episodes, early access, archive access, curated playlists and sponsor-free listening. Learn more at plus.npr.org.
DEA agents conduct operation at West Knoxville business
KNOXVILLE, Tenn. (WATE) — Federal drug investigators were spotted at a business in West Knoxville on Tuesday. A spokesperson for the Louisville Field Division of the Drug Enforcement Administration…
Attempted kidnapping, break-in at day care likely tied to mental health issues, docs say
Two separate incidents, which according to court documents, are likely related to mental health issues and drug psychosis.
There’s a right way to regulate drugs. Kratom is no exception.
Kratom, social media use in teens, New York's data center moratorium and more, in readers' eyes.
Automated Neurofeedback: Rewiring the Future of Mental Health Care
Mental health and addiction disorders continue to rise across the United States, affecting veterans, adolescents, families, first responders, and entire communities. According to the National Institute on Drug Abuse, nearly half of individuals with a substance use disorder also experience a co-occurring mental health condition. At the same time, healthcare systems are struggling with workforce ...
WVU Health leadership failed to address painkiller thefts as opioids devastated West Virginia
WVU Health Systems has entered into a federal settlement for failing to report and prevent drug thefts by employees.
FDA’s Home as a Health Care Hub Initiative and the READI-Home Innovation Challenge: Key Takeaways for Device Sponsors
Key Takeaways The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) opened its READI-Home Innovation Challenge, offering up to nine device sponsors early,…
Anthropic's life sciences plans: Mystery programs, Nobel hires, M&A and big ambition
Anthropic pushes into life sciences with a $400M Coefficient Bio deal, Nobel hire John Jumper, Claude Science launch and its own drug pipeline.
The next step of site-neutral, and a fiery PBM hearing
Medicare proposes to reduce payments to hospitals for certain drugs and imaging services.
Need surgery or prescriptions? How to deal with prior authorization challenges
Prior authorization: Why insurers require approval for some drugs, tests and procedures.
New Poll: 94% of Americans Say Congress Must Act on Health Care Costs, as Families USA Convenes Bipartisan Policy Symposium
Both House and Senate committees are marking up legislation on hospital price transparency, prescription drug and Medicare Advantage reform. WASHINGTON, D.C. – A new national poll shows that 94% of Americans believe it is important for the President and Congress to take action to lower health care costs. The poll was commissioned by Families USA, […]
Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
The pharmaceutical company has demonstrated how AI can transform how drugs discovery and is now scaling AI across R&D to accelerate the discovery of next-generation medicines.
Test that found source of US explosive diarrhoea outbreak was false positive, health officials say
The latest update from the US Food and Drug Administration means the exact source of the parasite is still not known.
U.S. health agency now says cyclospora finding at produce company was false positive
The U.S. Food and Drug Administration said on Sunday that laboratory experts re-reviewed sample results in the Taylor Farms Cyclospora investigation and concluded the finding should be considered a false positive.
Scientists discover a protein that protects the brain from Alzheimer’s damage
A protein called SORLA may act as a powerful defense against the toxic tau tangles involved in Alzheimer’s disease. Mice with extra SORLA had less tau accumulation, less brain atrophy, and healthier connections between neurons, while mice without it experienced more severe damage. The findings also revealed a possible drug target that could help control harmful activity in supporting brain cells.
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
Opinion | Double standard over GLP-1 drugs hits women especially hard
Women experience the effects of obesity in many ways, including heart disease, certain cancers, fertility challenges, maternal health complications, and more severe menopause symptoms.
Weight-loss drugs may improve job prospects and dating odds for one group
A weight-loss specialist says GLP-1 results boost confidence in job interviews and dating, but the study found no clear improvement in well-being.
GSK’s drops chronic cough drug, dampening $2bn Bellus Health bid
GSK will discontinue camlipixant’s late-stage RCC programme, though it will continue the drug’s development in two forms of IBS.
U.S. health officials zero in on source of Cyclospora outbreak
The U.S. Food and Drug Administration (FDA) is zeroing in on the source of a parasitic outbreak linked to iceberg lettuce that has sickened hundreds of people across five states.
I've been on PrEP for 11 years. Access to the HIV prevention drug is in danger.
Several interconnecting barriers continue to hinder PrEP access and exacerbate HIV prevention disparities.
The great 340B debate: Point vs. counterpoint vs. finger points
From the right come heated calls for reform if not outright overhaul of the 340B Drug Pricing Program. From the left, vociferous insistence on letting 340B be, albeit with modest tweaks and fixes. From hospitals and drug manufacturers: finger-pointing.
New Alzheimer's drug repairs DNA damage and reduces brain inflammation
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
SF overdose deaths decline as public health officials expand treatment, drug monitoring
Overdose deaths in San Francisco have declined compared to last year, a trend local public health officials say reflects both national patterns and the city's ongoing efforts to expand treatment and other interventions.
Trump officials want to make testosterone drugs easier to prescribe. Is that a good idea?
Officials under President Donald Trump want to make it easier for men to get a prescription for testosterone, the latest shift in a decades-long debate over the benefits and risks of replacing the hormone that affects sex drive, mood and other health factors.
Boone Co. man sentenced for major drug bust at Roscoe business
A Caledonia man finds out his prison sentence after pleading guilty to trafficking fentanyl and methamphetamine in 2022.
Jillian Michaels warns against social media health advice as ‘healthmaxxing’ trend goes viral
‘Keeping It Real’ podcast host Jillian Michaels discusses the viral ‘healthmaxxing’ trend and GLP-1 drugs on ‘Fox & Friends.’
Merck’s cholesterol pill gets US FDA approval
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s nod, bolstering the drugmaker’s efforts to diversify beyond its blockbuster cancer treatment Keytruda.
South Los Angeles business owner says crime, drug activity push neighborhood to breaking point
A South Los Angeles business owner says ongoing crime, drug activity and trash outside his auto body shop have created unsafe conditions.
Californian pair indicted for operating darknet drug trafficking business in U.S. and South Florida
Two suspects from California accused of running a darknet drug trafficking business throughout the U.S. and in Miami-Dade and Broward counties were indicted on Wednesday, authorities said.
Sunscreen gets an upgrade | Investors Lab
There are hundreds of brands of sunscreen available in the United States, but not one of them contains an ingredient we all need. Bemotrizinol, a highly effective, broad-spectrum chemical ultraviolet ray blocker, has been available in Europe for decades but absent from U.S. shelves. The regulatory bottleneck was driven by a 2011 U.S. Food and Drug Administration policy classifying sunscreens as drugs. While the classification remains, consumers and innovators can welcome the news that the FDA has officially approved bemotrizinol, effective August 9, 2026. Science News's Meghan Rosen provides the coverage.
Eli Lilly is reinventing the pharma business
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
Chairman Griffith Delivers Opening Statement at Subcommittee on Health Markup of Three Bills Combatting Illicit Drug Threats
The Committee on Energy and Commerce is the oldest standing legislative committee in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee.
OpenAI’s IPO Conundrum | AI & Business for July 14
Plus, Apple’s legal sparring, and Wall Street’s problem with AI drug discovery.
Weight-loss drugs didn't improve mental health or job prospects
The non-health benefits haven't been studied as closely as the health benefits.
‘The Ring’ star Daveigh Chase left an estate worth $400K after her death at 35
‘The Ring’ and ‘Lilo & Stitch’ star Daveigh Chase left an estate worth $400,000 after her death at 35 from AIDS and drug use.
Asheville wellness business owner accused of illegally prescribing GLP-1 drug
The owner of an Asheville wellness business is facing 10 felony charges after investigators accused her of diagnosing clients without a medical license in N.C.
Germany pushes through healthcare reform package despite pharma's drug discount resistance
Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own government, German lawmakers late Friday voted to pass health insurance ref | Even as the effort has met with fierce pushback, German lawmakers late Friday voted to pass health insurance reforms aiming to cut healthcare costs, in part by hiking up mandatory rebates that pharmas must pay on branded medicines.
How Unaffordable is Health Care and What Can We Do About It?
For decades, the cost of medical care, prescription drugs and health insurance has consistently risen faster than general inflation and wage growth, posing financial challenges for government, businesses and people.
Integrating AI as a Human-Guided Tool in Translational Science
Peter Tummino of Nimbus Therapeutics explains how drug discovery and development experts can apply AI across targeted workflows with intention and creativity.
India seeks to quash Adani airport's nicotine pouch court challenge citing illegality, health risk
The Indian government has argued the airport sale of nicotine pouches is a "substantive violation" of drug laws and a "serious public health risk", seeking to throw out Adani Group's bid to overturn an official finding that it broke the law by selling the unlicensed products at Mumbai's airport.
GLP-1s are latest wedding trend that has serious implications
Doctors worry the drugs are becoming a wedding fad as online prescribing makes them easier to obtain.
Who’s more to blame for frustration at the pharmacy—insurers changing formularies or prescribers failing to keep up?
Patients increasingly wait for—or never receive—drug treatments deemed appropriate and timely by their doctors.
Who’s more to blame for dashed ‘scrip’ fills—insurers restricting drug coverage or prescribers failing to keep up?
Patients increasingly wait for—or never receive—drug treatments deemed appropriate and timely by their doctors.
At Family Science Night, Wonder Comes Before Answers.
BAR HARBOR—Family Science Night isn’t really about science. It’s about wonder. It’s about watching a five-year-old realize that the tiny creature under a microscope is a real living thing. It’s about a teenager discovering that the scientist explaining genetics or regeneration isn’t much older than they are. It’s about parents seeing curiosity spread across a child’s face the way excitement spreads across a crowd at a Fourth of July parade. For one evening, families realize that the laboratory isn’t some secretive place where knowledge is hidden behind white coats and closed doors. They learn that the lab is a place their neighbors work, their friends’ parents work, and it becomes a place where questions matter more than answers. It’s a place where wonder is the origin for knowledge. At the lab, children learn that it’s okay not to know. Adults remember that they once asked “Why?” about everything. Scientists are reminded why they fell in love with discovery in the first place. There are experiments, games, obstacle courses, and demonstrations, of course. But those are really just invitations—to touch, to explore, to laugh, to make mistakes, and to ask one more question. In a world that often rewards certainty, Family Science Night celebrates curiosity. And perhaps that’s its greatest gift. Long after the microscopes are packed away and the experiments are over, what families take home isn’t just a few new facts about biology. They take home the feeling that discovery belongs to everyone—that science isn’t something happening somewhere else by someone else. It’s simply what happens when people are given permission to wonder. A Family Science Night at the Mount Desert Island Biological Laboratory is one of those rare community events where children and adults can experience science as something they do, not just something they read about. Hands on discovery allows hands-on learning and joy. Real scientists, some local, some scientist-interns (but still scientists) just in college make science real, approachable, and exciting. And there, complex ideas like forever chemical-filtration, DNA and so much more become not complex. Instead, they become fun. Summer fellows are challenged to explain cutting-edge biomedical research in ways a first-grader—and their grandparent—can understand. Past activities have explored gene expression, kidney function, axolotl regeneration, worms, microplastics, and phytoplankton through games and creative demonstrations. Though it’s called family night, you can also see adults going from station to station, exploring, learning together across ages. Family Science Night reflects the laboratory’s broader mission of breaking down barriers between researchers and the public, helping people understand how scientific discoveries relate to everyday life and the health of Maine’s environment. Family Science Night transforms a world-class research laboratory into a giant interactive classroom, where curiosity is encouraged, questions are celebrated, and families discover that science isn’t just something that happens in a lab—it’s an adventure anyone can join. About MDI Biological Laboratory For more than 125 years, MDI Bio Lab has been a center for training and research in comparative biology. In the last two decades its biomedical research has focused on aging, regeneration, and environmental toxins. The Laboratory houses 11 research groups staffed by an international team of world-class scientists and graduate students. It also leads a statewide network of colleges, universities and research institutions that collaborate to provide training, research experiences and financial support to help young Mainers play a bigger role in today’s biomedical revolution. Located on Maine’s rugged coast, the Laboratory’s 100+ acre campus houses research facilities, cottages and dorms that house visiting scientists and students. It is also home to MDI Bioscience, a subsidiary working to design innovative techniques to speed the drug discovery process. LINKS TO LEARN MORE NIH INBRE MDI BIOLOGICAL LABORATORY Photos: Carrie Jones and Shaun Farrar/Bar Harbor Story HELP SUPPORT THE BAR HARBOR STORY When we started The Bar Harbor Story, we didn’t know if anyone would read it. But you showed up. You shared. You sent tips. Now—over 400,000 views every month later—it’s clear: people here care about their community and each other. We’ve kept everything free because news should never be out of reach, but every one of our stories takes time to write, and your support keeps The Bar Harbor Story going. If you value our work, please consider a paid subscription, a founding membership, or a sponsorship. It truly helps us cover one more meeting, tell one more story, shine one more light. Even $5 a month makes a difference. Click here to become a one-time supporter now. Thank you so much for being here. Founding member information can be found here. Have questions about sponsorships? Just send Shaun an email at sfarrar86@gmail.com, he’d love to hear from you. Subscribe Share Bar Harbor Story Share Leave a comment
Scientists’ Side Hustle? Using AI and Quantum Computing to Generate New Peptides
Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help underserved populations and combat rare diseases.
Big Medicine threatens your wallet and your health. But there is a solution.
The Break Up Big Medicine Act has bipartisan support, and builds on new laws restricting pharmacy benefit managers.
UK becoming ‘wild west’ for experimental peptides, expert warns
Prof Channa Jayasena says growing online sales of unregulated drugs risk fatalities as responsibility falls between regulators
Waiting for insurance coverage for GLP-1s for weight loss? Keep waiting.
The corporations that pay for private employee health insurance are not ready to swallow the high costs of the enormously popular drugs, said the CEO of CVS Health.
Experimental drug reverses severe fatty liver disease by repairing the gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door to a new class of treatments for MASH and potentially other diseases tied to gut health.
Eight school-based health clinics close in Southwest Virginia as federal funding pressures mount
The outreach program had served as an extension of health services into communities where access to primary care is limited. It has been funded by reinvesting savings from a federal drug pricing program back into the communities the clinics serve.
GLP-1 drugs linked to long-term benefits for PAD patients
PAD patients treated with GLP-1 receptor agonists lived longer, stayed out of the hospital more and experienced fewer amputations than those given metformin.
GLP-1 drug popularity is outpacing the science, Madison doctor says
Dr. David Harris at UW-Madison says weight loss drugs like Ozempic, Wegovy and Zepbound are safe, so long as patients get the medications from doctors.
Germany's lower house of parliament passes healthcare reform
Germany's lower house of parliament on Friday approved a bill to overhaul the creaking health insurance system that has drawn fierce opposition from drugs companies which fear tougher pricing measures will harm profitability and reduce investment.
After Five Years of Business-Backed Advocacy, Governor Kehoe Signs Clean Slate Reforms Into Law
Today, Missouri Gov. Mike Kehoe signed SB 1421 into law, which included a bipartisan "Clean Slate" measure that establishes an automated process to identify and expunge eligible low-level drug offenses for thousands of Missourians. Working in partnership with the Responsible Business Initiative for Justice, business leaders and employers were among the most vocal supporters of the reform, calling it both a practical workforce solution that removes unnecessary barriers between qualified workers a
Roche ends two Huntington’s disease drug programmes after disappointing results
⏱️ 10 min read | Roche announced it is stopping development of two of its huntingtin-lowering ASO drugs, tominersen and RG6496. This marks a disappointing end to an important chapter in HD clinical research.
Revere uses opioid settlement money to enlist businesses in the fight against overdoses
A special program sends nurses who contract with the city to businesses including stores, restaurants, gas stations, barbershops and banks to train workers on how to use the overdose-reversal drug naloxone.
Surprising Mental Health Effects of GLP-1 Weight Loss Drugs
GLP-1 medications may be used to treat select psychiatric disorders.
The Ozempic and Wegovy mistake sending thousands to poison control
Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, with researchers linking the increase to accidental dosing mistakes rather than intentional misuse. Simple education about proper weekly dosing and gradual dose increases could help prevent many of these avoidable incidents.
Sen. Mitch McConnell’s constituents deserve transparency
Mitch McConnell's health, Nixon’s war on drugs, 'Take Me Home, Country Roads' and more, in readers' eyes.
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.
Scientists finally crack nature's secret for building better cancer drugs
Researchers have cracked the code behind bacteria's ability to naturally manufacture multiple versions of powerful anti-cancer drugs. The discovery could make it much easier to engineer new cancer treatments inspired by nature, including improved versions of existing medicines.
New weight loss pill beats oral Ozempic in major trial
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.
Oregon eyes $421 million in Medicaid cuts, including fewer benefits and limits on prescription drugs
Major cuts are coming to the Oregon Health Plan, the state’s free healthcare program covering 1.4 million children and low-income adults. But the group of experts Gov. Tina Kotek charged with minimizing the harm of those cuts has given her no definitive recommendations.
The crumbling employer-based health insurance system
Today's D.C. Diagnosis newsletter covers maintaining diversity in drug trials and troubling trends in employer-based health insurance.
Burnham urged to ditch ‘dangerous’ UK-US NHS drug deal
Exclusive: health groups call on expected next prime minister to rip up agreement, which analysis suggests could lead to 229,000 excess deaths by 2036
Andrew Gillum arrested on drug charges in Alabama, could face prison time
He faces 3 counts, including a felony.
How easy is it to get weight-loss drugs online? Secret shoppers from Yale found out.
The quality of care by online providers offering lower-cost knockoff versions of weight loss drugs is an increasingly urgent issue.
Socialist mayor Katie Wilson silent amid protests over ‘human dumping ground’ ahead of US World Cup match
CID businesses report a major decline in foot traffic during the FIFA World Cup as residents protest Mayor Katie Wilson over crime and drug dealing.
Charlotte patients turn to ketamine therapy for mental health treatment
The club drug once known as "Special K" is becoming an unlikely treatment for depression.
Ipsos poll offers new snapshot of Americans' views on health care and GLP-1 drugs
Church services dull pain, and a new diabetes drug: science stories of the week
From new types of spider hunting techniques to the earliest-known plague victims, here are the most interesting recent scientific developments
These Medicare beneficiaries thought their drug plan was free. Then they lost it
Thousands of people lost coverage over as little as $8 in delinquent payments. They didn't know their zero-dollar premiums had gone up and they owed money. Most now can't get coverage until 2027.
New study changes what scientists know about lithium and bipolar disorder
Lithium is one of the most effective drugs for bipolar disorder. However, its narrow therapeutic window means the difference between an effective dose and a toxic one is small.
A hidden weakness in deadly cancers could lead to powerful new treatments
A UCLA study has identified a hidden Achilles' heel in aggressive small cell cancers that have resisted new treatments for decades. Scientists found that tumors lacking the RB gene become critically dependent on the protein E2F3 for survival. Blocking E2F3 shut down tumor growth in laboratory models, and existing FDA-approved drugs may be able to exploit this vulnerability. The discovery could pave the way for faster development of more effective therapies.
The New Anthropic Tool That Could Change How Drugs Are Developed
Introducing Claude Science, the AI platform designed to expedite the discovery of promising new therapies. Anthropic will also use it in-house to pursue innovative treatments for 'neglected' diseases.
3 arrested, guns and drugs seized after Birmingham Police shut down ‘illegal business’
Birmingham Police announced they conducted a coordinated operation that resulted in the shutdown of an “illegally operating business.”
Illegal business shut down, guns and drugs found
Illegal business shut down, guns and drugs found
New HHS agenda targeting antidepressants creates pushback
As the Department of Health and Human Services creates new efforts to limit the overprescription of SSRI drugs, psychiatrists are pushing back.
FSU Health nurse practitioner arrested on drug fraud, falsifying medical records charges
A Tallahassee-based nurse practitioner is accused of obtaining prescription medications by prescribing them to her receptionists for her to pick up.
Dr. Oz on Medicare covering weight loss drugs, America's health innovation
Dr. Mehmet Oz discusses health innovation for America's 250th birthday, highlighting a new initiative where Medicare will cover GLP-1 weight loss medications for $50 a month, aiming to reduce health complications.
Anthropic Wants to Make Its Own Drugs With Help from Claude
The AI company is launching preclinical drug programs for overlooked diseases.
Anthropic wants to develop its own drugs
The AI drug boom has a long way to go before reaching patients.
Drug-resistant fungus Candida auris still on the rise in the U.S.
Candida auris can “colonize” the skin and spread easily to surfaces.
UVM Health to suspend weight loss drug coverage for its employees
The hospital said it would expect to save $19 million dollars each year, but staff are skeptical of the long-term costs.
Why you should wash new clothes before wearing; signs that you are aging well; effective leadership in health care; plus other stories with Vanderbilt Health sources
Jami Miller, MD, Professor of Clinical Dermatology, and David Gaston, MD, PhD, Assistant Professor of Pathology, Microbiology and Immunology, are quoted in a Southern Living piece about the importance of washing new clothes before wearing them. Dyes, chemicals, mold and bacteria are all potential troublemakers lurking around your new duds. Parul Goyal, MBBS, Associate Professor of Clinical Medicine, was quoted in a Huff Post story outlining signs that you are aging well. Tae Kon Kim, MD, PhD, Assistant Professor of Medicine, was interviewed by Healio for a story headlined, “Effective leadership in health care ‘starts with listening.’” AAMC News reporter Patrick Boyle interviewed Wes Ely, MD, Professor of Medicine and Critical Care, for a story about ICU delirium. PharmaVoice reporter Kelly Bilodeau interviewed Romney Humphries, PhD, Vice Chair and Executive Medical Director, Clinical Services, for a story about the CDC’s new data that shows an alarming increase in the prevalence of a gene that can make “nightmare bacteria” significantly harder to treat. American Community Media interviewed William Schaffner, MD, Professor of Preventive Medicine, for a piece about Ebola that was reused by several media outlets around the U.S., including The Mississippi Link. Stacie Dusetzina, PhD, Professor of Health Policy, was quoted by The Independent in a story about how Medicare will soon cover weight-loss drugs. Courtney Schadt, MD, Associate Professor of Dermatology, was interviewed by Tennessean reporter Beth Warren, about tanning safety and tanning fads circulating social media. WKRN News 2 interviewed Amanda Peltier, MD, Professor of Neurology, about the correlation between head trauma and ALS following the diagnosis of former Titans running back Chris Johnson.
Trump admin proposes rule it says could save Medicare patients $1.1B on drugs
The change would apply to hospitals that serve low-income patients
France Politics
France's President Emmanuel Macron chairs the fifth follow-up meeting on combating drug trafficking, at the Elysee presidential Palace in Paris, Thursday July 2, 2026. (Simon Wohlfahrt/Pool Photo via AP)
Drug overdose spike in Madison could be related to extreme heat
First responders in Dane County reported at least seven overdoses involving opioids June 29 and 30. No spike has been seen in Milwaukee County yet.
Over-40s with obesity have normal-BMI cholesterol and blood pressure levels, study finds
Success of statins and blood-pressure drugs hailed as researchers find some people with obesity were ‘better off’
Statins and blood pressure drugs changing health risks of obesity, study suggests
New research shows obesity patients over 40 are managing blood pressure and cholesterol as well as healthy-weight peers, but younger adults remain at risk.
Anthropic Goes Deeper Into Drug Development With Claude Science
The company launched an app designed as an AI workbench that brings together the vast array of tools used in scientific research and also said it is getting into drug development.
Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs
Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an important role for patients.